Skip to main content
Innovations in Pharmacy logoLink to Innovations in Pharmacy
. 2020 Dec 10;11(4):10.24926/iip.v11i4.3348. doi: 10.24926/iip.v11i4.3348

Prescription Adaptation Services: A Win for Patients and Providers

Alex J Adams 1,
PMCID: PMC8127108  PMID: 34007646

Abstract

“Prescription adaptation services” (PAS) refers to the ability of pharmacists “to adapt an existing prescription when, in their professional judgment, the action is intended to optimize the therapeutic outcome of treatment.” If structured appropriately, PAS can provide a benefit in enhancing the timeliness of patient care, while reducing the administrative burden on both physicians and pharmacists. Moreover, it leverages the strengths of both health professions, specifically the medication expertise of pharmacists. Unfortunately, in most states it will require a change in regulations in order to enable PAS.


“Prescription adaptation services” (PAS) refers to the ability of pharmacists “to adapt an existing prescription when, in their professional judgment, the action is intended to optimize the therapeutic outcome of treatment.”1 In essence, adaptation occurs when a pharmacist modifies an existing prescription issued by another licensed practitioner in order to improve patient care. As such, PAS may be key to reducing the significant administrative burdens that physicians and pharmacists face on the frontlines that ultimately delay patient care.

Examples of Burdens and Delays in Practice

Consider a case in which a physician prescribes Ventolin®. The patient presents the prescription to the pharmacy, the pharmacist adjudicates the claim with the patient’s health plan, and the claim is denied because ProAir® is the health plan’s preferred albuterol inhaler. In order to dispense Ventolin® as prescribed, prior authorization is needed from the plan. The pharmacist calls the physician’s office to ascertain their preferred next step, but because a conversation between the pharmacist and physician is unlikely to occur in real time, the patient leaves the pharmacy empty handed and will have to make a second trip to the pharmacy once the matter is resolved. Unfortunately, primary medication non-adherence rates are such that some patients may never return.2

Many similar examples abound:

  • Prescribers may select a package size for a cream that is not commercially available.

  • A patient may be on vacation and left their blood pressure medication at home.

  • A prescriber may have inadvertently left off a quantity on a medication that is taken daily and is generally written in increments of a 30-day supply.

  • A patient may prefer a liquid formulation of a drug instead of the capsule.

In each case, the end result is the same: the pharmacist cannot act without contacting the prescriber and obtaining their consent, no matter how commonsense the situation. In addition, the patient is left waiting without their needed medication.

Complications at the pharmacy counter are, in part, why leading national medical associations have all called for efforts to reduce the excessive administrative burdens that physicians face.35 One study found the average physician spends 8.7 hours per week on administrative work, which resulted in lower career satisfaction.6 One study estimated physicians spend more than 60 minutes each day addressing prescription issues, with an estimated cost to the medical practice of $5-$7 per pharmacy call.7 A study of primary care practices logged 567 clarification calls over a two week period, primarily related to prior authorizations (37%), formulary issues (26%), and unclear/missing dosages (21.7%).8 The same study found 34% of the problems were not resolved on the same day even when an acute medication was involved.8

Such issues are similarly burdensome to pharmacists. Community pharmacists reported spending 8% and 6% of their work week communicating with other health care providers from independent and chain settings, respectively.9 These pharmacists reported this time as a major barrier to good care, with one pharmacist lamenting the “time wasted” between the pharmacy, physician, and insurance.9

Role for Prescription Adaptation Services

This is where PAS, if structured appropriately, can really provide a benefit in enhancing the timeliness of patient care, while reducing the administrative burden on both physicians and pharmacists. Moreover, it leverages the strengths of both health professions, specifically the medication expertise of pharmacists.

Unfortunately, in most states it will require a change in regulations in order to enable PAS. Privately, some pharmacists will confide they already practice in this manner as it is in the best interest of patient care, but state law generally delineates what must be on a prescription in order for it to be valid, and limits the authority of pharmacists to make deviations from a prescription as ordered without prior prescriber consent.

Canadian provinces are much farther ahead than U.S. states with respect to enabling PAS; in Canada, the allowed PAS typically fall into two categories: 1) Renewals; and 2) Changes (e.g., changes to dispensing quantity, formulation, route of administration, complete missing information, and therapeutic substitutions).10

In its first year of operation in British Columbia, pharmacists performed 96,890 adaptations.1112 Continuation of therapy renewals were the most frequent adaptation (79.5%), followed by changes in dose (7.2%), formulation (4.9%), regimen (4.5%), and therapeutic substitutions (3.8%).10 Initially, physician feedback on adaptation services in Canada was generally negative.13 Despite these initial concerns, pharmacists noted that support increased in subsequent years, with the number of “do not adapt” prescriptions decreasing over time.14 The uptake of PAS has been small relative to the total number of prescriptions filled, but each adaptation represents a potential optimization in patient care. In addition, the 96,890 adaptations performed in the first year in British Columbia may have saved 96,890 calls between pharmacists and prescribers, leading to more efficient and timely care for patients.

For U.S. regulators to enable PAS, learning from the experience of Canadian provinces can be beneficial. The Idaho State Board of Pharmacy recently underwent a process to change its regulations to a “standard of care approach” that removes many prescriptive regulations with a goal of empowering pharmacists to practice to the top of their education and training.15 In so doing, the Idaho board enabled PAS for both renewals and certain changes. A summary of the Idaho regulations are enclosed in Table 1 as a potential starting point for other jurisdictions.16

Table 1. Sample PAS Regulations from Idaho.

Type of Adaptation

Rule Number16

Regulation16

Renew

402.03

“A prescription drug order may be refilled when permitted by state and federal law and as specifically authorized by the prescriber. A pharmacist may also refill a prescription for a non- controlled drug when the prescriber is not available for authorization.”

Change - Quantity

403.01

“A pharmacist may change the quantity of medication prescribed if:

a. The prescribed quantity or package size is not commercially available;

b. The change in quantity is related to a change in dosage form;

c. The change is intended to dispense up to the total amount authorized by the prescriber including refills; or

d. The change extends a maintenance drug for the limited quantity necessary to coordinate a patient’s refills in a medication synchronization program.”

Change – Dosage Form

403.02

“A pharmacist may change the dosage form of the prescription if it is in the best interest of patient care, so long as the prescriber’s directions are also modified to equate to an equivalent amount of drug dispensed as prescribed.”

Change – Complete Missing Information

403.03

“A pharmacist may complete missing information on a prescription if there is sufficient evidence to support the change.”

Change – Therapeutic Substitution

404.05

“A pharmacist may substitute a drug with another drug in the same therapeutic class provided the patient opts-in and the substitution lowers the cost to the patient or occurs during a drug shortage.”

Given the efficiency gains and commonsense nature of PAS, the Idaho regulations encountered little opposition. Some patient advocacy groups representing the mental health community expressed concern about how therapeutic substation could apply to psychotropic medications, a concern that has been raised in other jurisdictions.1718

The hallmark of Idaho’s PAS is retaining prescriber and patient choice.19 If a prescriber wants a patient on a specific medication or formulation, the prescriber can always request that the prescription be “dispensed as written” or a similar designation. Similarly, patients have to opt-in to accepting the change in prescription, retaining the patient’s autonomy in their own health care decisions.

Conclusion

PAS offers a rare win-win-win. Patients can receive their optimized medications sooner. Prescribers and pharmacists are better leveraged, and their administrative burden is reduced. Moreover, health plans benefit from enhanced formulary compliance without burdening their provider network. Additional jurisdictions may consider PAS as structured in Canada or Idaho as they pursue their own regulatory updates in the years ahead.

Acknowledgments

Funding Support: None

Conflicts of Interest: None

Disclaimer: The views expressed in this manuscript are those of the authors alone, and do not necessarily reflect those of the employer.

Acknowledgments: None

References


Articles from Innovations in Pharmacy are provided here courtesy of University of Minnesota Libraries Publishing

RESOURCES